The 100% rate on imported, branded pharma products will not apply to drugmakers constructing manufacturing facilities in the ...

Eli Lilly and Novo Nordisk are in a tight race to capture the lucrative oral obesity drug market – but how will their ...

Lithuania is rapidly growing as a leading force in the European life sciences scene, with over 400 life sciences companies in ...

Synaffix has entered a licensing agreement with South Korean biopharmaceutical firm Qurient to develop a dual-payload ADC.

AstraZeneca has launched an online direct-to-consumer (DTC) medicine platform in the US, joining a growing list of companies ...

Lilly has received approval from the US Food and Drug Administration (FDA) for Inluriyo (imlunestrant) to treat advanced ...

Mérieux Equity Partners has outlined its approach to investing in Lithuania and wider Europe, highlighting a particular focus ...

Evaxion’s preclinical asset targets an unknown infectious disease in which there are no other vaccines available.

Patients will now be able to access BMS' Sotyktu for significantly cheaper than current list prices, alongside BMS and Pfizer ...

After demonstrating that its gene therapy can slash Huntington's disease progression by 75%, Uniqure will now file for ...

Moderna has opened its new vaccine manufacturing and R&D facility in Oxfordshire, UK, the Moderna Innovation and Technology ...

Sanofi has committed an additional $625m to its venture capital arm, Sanofi Ventures, bringing its total assets under ...